The therapeutic use of 177 Lu-PSMA-617 radioligand therapy in prostate cancer treatment: a review of literature and ongoing trials by Alexander Konopnicki, Michael Zaliznyak, Mathews Roy, Bagi Jana

Subjects: Get full text

Robustness of textural analysis features in quantitative 99 mTc and 177Lu SPECT-CT phantom acquisitions by Alastair J. Gemmell, Colin M. Brown, Surajit Ray, Alexander Small

Subjects: Get full text

Radiosynovectomy of Painful Synovitis of Knee Joints Due to Rheumatoid Arthritis by Intra-Articular Administration of 177 Lu-Labeled Hydroxyapatite Particulates: First Human Study... by Ajit Shinto, K Kamaleshwaran, Sudipta Chakraborty, K Vyshakh, S Thirumalaisamy, S Karthik, V Nagaprabhu, K Vimalnath, Tapas Das, Sharmila Banerjee

Subjects: “…177 lu…”
Get full text

Preparation of novel zirconium phosphonates for adsorption of lutetium by Wanjun Mu, Baihua Chen, Xingliang Li, Hongyuan Wei, Yuchuan Yang, Shuming Peng

Subjects: “…177Lu…”
Get full text

177Lu-DOTATATE peptide receptor radionuclide therapy in metastatic or advanced and inoperable primary neuroendocrine tumors of rare sites by Pradeep Thapa, Rahul Parghane, Sandip Basu

Subjects: “…177lu-dotatate…”
Get full text

Stability in the production and transport of 177Lu labelled PSMA by Cristian Antonio Wieczorek Villas Boas, Luís Alberto Pereira Dias, Margareth Mie Nakamura Matsuda, Elaine Bortoleti de Araújo

Subjects: “…production of 177lu-psma-617…”
Get full text

Predictive factors for persistent thrombocytopenia after peptide receptor radioligand therapy in enteropancreatic neuroendocrine tumors by Romain Ferrara, Christophe Zemmour, Thibaut Reichert, Daniel Ouk, Patricia Niccoli, Jemima Maniry-Quellier, Isabelle Brenot-Rossi, Nathalie Charrier, Sandrine Oziel-Taieb

Subjects: “…[177Lu]Lu-DOTATATE…”
Get full text

Comparative Study of P507-impregnated Polystyrene and Polyacrylate Resins for Separation of Yb/Lu by FAN Xisheng, MA Guoquan, PENG Haiyue, GAO Jing, LI Feize, LAN Tu, LIAO Jiali, YANG Yuanyou, LIU Ning

Subjects:

Application of 68Ga‐ and 177Lu‐Labeled FAP Inhibitor in Evaluation and Treatment of Cardiac Fibrosis After Myocardial Infarction by Yiheng Zhao, Xiangyu Su, Boyang Xiang, Shuchen Zhang, Xiang Zhou

Subjects: Get full text

Toward the standardization of radiopharmaceutical therapies: a technical note evaluating a clinical dosimetry workflow for single-time-point 177Lu SPECT/CT-based therapies by Taehyung Peter Kim, Wendy Siman, Vivek Mishra, Santiago Aguirre, Siju C. George

Subjects: Get full text

Blood-based transcriptomic biomarkers for response to [177Lu]Lu-DOTA-TATE therapy in neuroendocrine tumors by Hyunpil Sung, Sungwoo Bae, Minseok Suh, Hongyoon Choi, Hyung-Jun Im, Gi Jeong Cheon, Keon Wook Kang

Subjects: Get full text

Mechanistic role of miR-375 in regulating PDPK1 to promote progression of small bowel neuroendocrine tumors: a silico analysis by Tao Ren, Lu Zhou, Zhenlong Li, Mingmei Pan, Xueqiong Han

Subjects: Get full text

Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy by Felix L. Herr, Christian Dascalescu, Victoria Fusch, Caroline Smith, Ricarda Ebner, Mathias J. Zacherl, Florian Eckenweber, Konrad Klimek, Christoph J. Auernhammer, Christine Spitzweg, Jens Ricke, Maurice M. Heimer, Clemens C. Cyran, Rudolf A. Werner, Gabriel T. Sheikh

Subjects: Get full text

Radiation exposure and protection advice after [177Lu]Lu-DOTA-TATE therapy in China by Fei Liu, Panli Li, Junyan Xu, Jianping Zhang, Xiaoping Xu, Zhihao Chen, Ying Qiao, Yun Liang, Jie Chen, Shaoli Song

Subjects: Get full text

Clinical efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in thyroglobulin-elevated negative iodine scintigraphy: A “not-so-promising” result compared to GEP-NETs... by Sandip Basu, Rahul Parghane, Chinna Naik

Subjects: “…177lu-dotatate…”
Get full text

The radiological response of patients with advanced bone metastases to lutetium-177-labeled DOTA-ibandronic acid assessed by metabolic tumor volume by Juan Yang, Lihan Zhang, Yue Chen

Subjects: Get full text

DETERMINATION AND EVALUATION OF LONG-TERM ABSORBED RADIATION DOSES OF RADIATION WORKERS WORKING IN TARGETED RADIONUCLIDE THERAPIES by Nazenin İpek Işıkcı, Mustafa Demir

Subjects: Get full text

177Lu-DOTATATE and 177Lu-prostate-specific membrane antigen therapy in a patient with advanced metastatic radioiodine-refractory differentiated thyroid cancer after failure of tyro... by Majid Assadi, Hojjat Ahmadzadehfar

Subjects: “…177lu…”
Get full text

Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN study by Rachele Danieli, Magdalena Mileva, Gwennaëlle Marin, Paulus Kristanto, Wendy Delbart, Bruno Vanderlinden, Zéna Wimana, Alain Hendlisz, Hugo Levillain, Nick Reynaert, Patrick Flamen, Ioannis Karfis

Subjects: “…[177Lu]Lu-DOTA-TATE…”
Get full text

Peptide receptor radionuclide therapy with 177Lu-DOTATATE for metastatic neuroendocrine tumor occurring in association with multiple endocrine neoplasia type 1 and cushing's syndro... by Chinna Naik, Sandip Basu

Subjects: “…177lu-dotatate…”
Get full text